Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R

被引：4
|
作者：
Laorden, Daniel [1 ,2 ]
Zamarron, Ester [1 ,2 ]
Romero, David [1 ,2 ]
Dominguez-Ortega, Javier [2 ,3 ]
Villamanan, Elena [4 ]
Losantos, Itsaso [5 ]
Gaya, Francisco [5 ]
Quirce, Santiago [2 ,3 ]
Alvarez-Sala, Rodolfo [1 ,2 ]
机构：
[1] Univ Autonoma Madrid, Hosp La Paz, Dept Pneumol, IdiPAZ, Paseo Castellana 261, Madrid 28046, Spain
[2] CIBER Resp Dis, Paseo Castellana 261, Madrid 28046, Spain
[3] Hosp La Paz, Dept Allergy, IdiPAZ, Madrid, Spain
[4] Hosp La Paz, Dept Pharm, IdiPAZ, Madrid, Spain
[5] Hosp La Paz, Dept Biostat, Madrid, Spain
来源：
RESPIRATORY MEDICINE | 2023年 / 211卷
关键词：
Asthma; FEOS score; Super-responder; Asthma remission; Anti-IL5; Anti-IL5R; Biologic treatment; Mepolizumab; Benralizumab; Reslizumab;
D O I：
10.1016/j.rmed.2023.107216
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：5
相关论文
共 17 条
  • [1] Are serum immunoglobulin concentrations a predictive biomarker of response to anti-IL5/IL5Rα therapies?
    Lauret, Simon
    Noel-Savina, Elise
    Prevot, Gregoire
    Guibert, Nicolas
    Reber, Laurent
    Brouquieres, Daniele
    Didier, Alain
    Guilleminault, Laurent
    RESPIRATORY MEDICINE AND RESEARCH, 2022, 81
  • [2] Changing between anti-IL5 and anti-IL5 receptor treatments. A real-life study
    Bjerrum, Anne Sofie
    Skjold, Tina
    Andersen, Helle
    Pedersen, Lene
    Schmid, Johannes
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [3] Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission
    Carpagnano, Giovanna Elisiana
    Portacci, Andrea
    Nolasco, Santi
    Detoraki, Aikaterini
    Vatrella, Alessandro
    Calabrese, Cecilia
    Pelaia, Corrado
    Montagnolo, Francesca
    Scioscia, Giulia
    Valenti, Giuseppe
    D'Amato, Maria
    Caiaffa, Maria Filomena
    Triggiani, Massimo
    Scichilone, Nicola
    Crimi, Claudia
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [4] Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study
    Maglio, Angelantonio
    Vitale, Carolina
    Pelaia, Corrado
    D'Amato, Maria
    Ciampo, Luigi
    Sferra, Eliana
    Molino, Antonio
    Pelaia, Giulia
    Vatrella, Alessandro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [5] Determining early response to anti-IL5/IL5R monoclonal antibodies in severe eosinophilic asthma
    Kavanagh, Joanne
    Roxas, Cris
    Green, Linda
    Fernandes, Mariana
    Thomson, Louise
    Payne, Victoria
    Hearn, Andrew
    Kent, Brian D.
    D'Ancona, Grainne
    Dhairwal, Jaideep
    Nanzer, Alexandra M.
    Jackson, David J.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [6] Anti-IL5/IL5R Treatment in COPD: Should We Target Oral Corticosteroid-Dependent Patients?
    Laroche, Jeremy
    Pelletier, Genevieve
    Boulay, Marie-Eve
    Cote, Andreanne
    Godbout, Krystelle
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 755 - 763
  • [7] A comparison of the impact of anti-IL5/5r therapies in allergic versus non-allergic patients with severe eosinophilic asthma in a real-life setting
    Navarro-Cascales, Tatiana
    Colque-Bayona, Monica
    Fernandez-Concha, Ines
    Laorden, Daniel
    Quirce, Santiago
    Dominguez-Ortega, Javier
    JOURNAL OF ASTHMA, 2025, 62 (02) : 319 - 327
  • [8] Impact of Anti-IL5 Therapies on Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study
    Rojo-Tolosa, Susana
    Gonzalez-Gutierrez, Maria Victoria
    Jimenez-Galvez, Gonzalo
    Sanchez-Martinez, Jose Antonio
    Pineda-Lancheros, Laura Elena
    Galvez-Navas, Jose Maria
    Jimenez-Morales, Alberto
    Perez-Ramirez, Cristina
    Morales-Garcia, Concepcion
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [9] Nasal Symptoms in Asthmatic Patients under Treatment with Anti-IL-5 Monoclonal Antibodies. A Real-Life Cohort Study
    Maza-Solano, Juan
    Calvo-Henriquez, Christian
    Alobid, Isam
    Alvarez-Cendrero, Marta
    Palomares, Oscar
    Moreno-Luna, Ramon
    Santos-Perez, Jaime
    Gonzalez-Garcia, Jaime
    Sanchez-Gomez, Serafin
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [10] Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients
    Valverde-Monge, Marcela
    Sanchez-Carrasco, Patricia
    Betancor, Diana
    Barroso, Blanca
    Rodrigo-Munoz, Jose Manuel
    Mahillo-Fernandez, Ignacio
    Arismendi, Ebymar
    Bobolea, Irina
    Cardaba, Blanca
    Cruz, Maria Jesus
    Del Pozo, Victoria
    Dominguez-Ortega, Javier
    Gonzalez-Barcala, Francisco Javier
    Olaguibel, Jose Maria
    Luna-Porta, Juan Alberto
    Martinez-Rivera, Carlos
    Mullol, Joaquim
    Munoz, Xavier
    Peleteiro-Pedraza, Lorena
    Valles, Cesar Picado
    Plaza, Vicente
    Quirce, Santiago
    Rial, Manuel Jorge
    Soto-Retes, Lorena
    Valero, Antonio
    Sastre, Joaquin
    ARCHIVOS DE BRONCONEUMOLOGIA, 2024, 60 (01): : 23 - 32
12